Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Atossa Therapeutics Q2 Earnings

  Atossa Therapeutics (NASDAQ:ATOS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Atossa Therapeutics (NASDAQ:ATOS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM.

Here’s what investors need to know about the announcement.

Earnings

Atossa Therapeutics beat estimated earnings by 16.67%, reporting an EPS of $-0.05 versus an estimate of $-0.06.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 3.56% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Atossa Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For FirstService

By Benzinga Insights
Today, 3:26 PM
FirstService (NASDAQ:FSV) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that FirstService will report an earnings per share (EPS) of $1.20.

FSV